LACRIMERA®
Description
LACRIMERA® forms a physiological glycocalyx on the ocular surface. The eye drops form a covalent binding with the cell surface mucin layer. The multi-patented mode of action allows a 24 hour retention time on the ocular surface to treat cornea erosions and dry eye. The protection shield forms a bandage thereby supporting the healing effect on the epithelium.
Winner
Excellence in Business to Consumer
Medical & Health Company Croma-Pharma GmbH Development Croma-Pharma GmbH Share
Medical & Health Company Croma-Pharma GmbH Development Croma-Pharma GmbH Share